AI in Drug Discovery Market: Emerging Technologies and Innovations 2035
Deploying AI Across the Early-Stage Discovery Pipeline Artificial intelligence addresses specific bottlenecks throughout early drug discovery, primarily in two critical phases: target identification/validation and lead candidate optimization. While both phases utilize computational models, their underlying datasets and computational objectives differ substantially. In target identification and...
0 Commentarios 0 Acciones 3 Views 0 Vista previa
Comunidad EDUCA https://comunidadeduca.com